LEXEO Therapeutics Company
LEXEO Therapeutics is a biotechnology company.
Investors
Headquarters:
New York, New York, United States
Industry:
Early Drug Development
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
16.0
Funding Status:
Early Stage Venture
Last Funding Type:
Series B
Founded Date:
2018-01-01
Total Funding:
185000000.0
Last Funding Date:
2021-09-09